Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Evaluation of ISTH DIC Score to Predict Significant Bleeding and Thrombosis Events in Pediatric Acute Promyelocytic Leukemia; A Report from the Children’s Oncology Group AAML0631 Trial

Matthew A. Kutny, MD, Madhvi Rajpurkar, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Alan S. Gamis, MD MPH, James H. Feusner, MD, John Gregory, MD

Blood (2014) 124 (21): 3669.

https://doi.org/10.1182/blood.V124.21.3669.3669

Published: 2014

Journal Articles

Arsenic Trioxide Is a Well Tolerated Consolidation Regimen in Children with Newly Diagnosed Acute Promyelocytic Leukemia; Toxicity Results of the Children’s Oncology Group AAML0631 Trial

Matthew A. Kutny, MD, Todd A. Alonzo, PhD, Robert B. Gerbing, MA, Yi-Cheng Wang, MS, Cecilia Fu, MD, Soheil Meshinchi, MD PhD, Alan S. Gamis, MD MPH, James H. Feusner, MD, John Gregory, MD

Blood (2014) 124 (21): 985.

https://doi.org/10.1182/blood.V124.21.985.985

Published: 2014

Journal Articles

Effect of Young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

Matthew A. Kutny, MD, Susan Geyer, PhD, Kristina M Laumann, BA, John Gregory, MD, Cheryl L. Willman, MD, Wendy Stock, MD, Richard A. Larson, Bayard L. Powell, MD, James H. Feusner, MD

Blood (2014) 124 (21): 2301.

https://doi.org/10.1182/blood.V124.21.2301.2301

Published: 2014

Journal Articles

A Comparison of Outcomes Between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

Matthew A. Kutny, MD, Susan Geyer, PhD, Kristina M Laumann, BA, John Gregory, MD, Cheryl L. Willman, MD, Wendy Stock, MD, Richard A. Larson, Bayard L. Powell, MD, James H. Feusner, MD

Blood (2014) 124 (21): 2306.

https://doi.org/10.1182/blood.V124.21.2306.2306

Published: 2014

Journal Articles

Obesity Does Not Affect the Recurrence Free Survival Rates in Children Less Than 20 Years of Age in Acute Promyelocytic Leukemia (APL)

Ji Heon (Paul) Lee, MDPhD, Alfred W. Rademaker, PhD, Bayard L. Powell, MD, Susan Geyer, PhD, Richard A. Larson, John Gregory, MD, Nobuko Hijiya, MD, James H. Feusner, MD

Blood (2014) 124 (21): 957.

https://doi.org/10.1182/blood.V124.21.957.957

Published: 2014

Journal Articles

Adding Mercaptopurine and Methotrexate to Alternate Week ATRA Maintenance Therapy Does Not Improve the Outcome for Adults with Acute Promyelocytic Leukemia (APL) in First Remission: Results From North American Leukemia Intergroup Trial C9710

Bayard L. Powell, MD, Barry K Moser, Ph.D., Wendy Stock, MD, Robert E. Gallagher, MD, Cheryl L Willman, MD, Richard M. Stone, MD, Jacob M. Rowe, MD, Steven E. Coutre, MD, James H. Feusner, M.D., John Gregory, MD, Stephen Couban, MD, FRCPC, Frederick R. Appelbaum, MD, Martin S. Tallman, MD, Richard A. Larson, MD

Blood (2011) 118 (21): 258.

https://doi.org/10.1182/blood.V118.21.258.258

Published: 2011

Journal Articles

FLT3 Mutations Are Prevalent and Are Significantly Associated with Induction Death In Pediatric Acute Promyelocytic Leukemia, a Report From the Children's Oncology Group

Matthew A. Kutny, MD, Barry K. Moser, PhD, John Gregory, MD, William G. Woods, MD, James H. Feusner, MD, Soheil Meshinchi, MD, PhD

Blood (2010) 116 (21): 753.

https://doi.org/10.1182/blood.V116.21.753.753

Published: 2010

Journal Articles

Preliminary Results from the North American Acute Promyelocytic Leukemia (APL) Study C9710.

Bayard L. Powell, MD, Barry Moser, MD, Wendy Stock, MD, Robert E. Gallagher, MD, Cheryl L. Willman, MD, Richard M. Stone, MD, Jacob M. Rowe, MD, Steven Coutre, MD, James H. Feusner, MD, John Gregory, MD, Stephen Couban, MD, Frederick R. Appelbaum, MD, Martin S. Tallman, MD, Richard A. Larson, MD

Blood (2006) 108 (11): 566.

https://doi.org/10.1182/blood.V108.11.566.566

Published: 2006

Journal Articles

Obesity in Newly Diagnosed Childhood Acute Promyelocytic Leukemia.

James Feusner, MD, Haesook Kim, PhD, John Gregory, MD, Todd Alonzo, PhD, William Woods, MD, Howard Weinstein, MD, Martin Tallman, MD

Blood (2006) 108 (11): 4494.

https://doi.org/10.1182/blood.V108.11.4494.4494

Published: 2006

Journal Articles

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

John Gregory, MD, Haesook Kim, PhD, Todd Alonzo, MD, Rob Gerbing, PhD, Angela Ogden, MD, William Woods, MD, Howard Weinstein, MD, Lois Shepherd, MD, Charles Schiffer, MD, Frederick Appelbaum, MD, Cheryl Willman, MD, Peter Wiernik, MD, Jacob Rowe, MD, Martin Tallman, MD, James Feusner, MD

Blood (2005) 106 (11): 894.

https://doi.org/10.1182/blood.V106.11.894.894

Published: 2005

NARROW

Evaluation of ISTH DIC Score to Predict Significant Bleeding and Thrombosis Events in Pediatric Acute Promyelocytic Leukemia; A Report from the Children’s Oncology Group AAML0631 Trial

Arsenic Trioxide Is a Well Tolerated Consolidation Regimen in Children with Newly Diagnosed Acute Promyelocytic Leukemia; Toxicity Results of the Children’s Oncology Group AAML0631 Trial

Effect of Young Age on Outcomes in Pediatric Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

A Comparison of Outcomes Between Adolescents and Young Adults (AYA) and Children with Acute Promyelocytic Leukemia (APL): North American Intergroup Study CALGB 9710 (Alliance)

Obesity Does Not Affect the Recurrence Free Survival Rates in Children Less Than 20 Years of Age in Acute Promyelocytic Leukemia (APL)

Adding Mercaptopurine and Methotrexate to Alternate Week ATRA Maintenance Therapy Does Not Improve the Outcome for Adults with Acute Promyelocytic Leukemia (APL) in First Remission: Results From North American Leukemia Intergroup Trial C9710

FLT3 Mutations Are Prevalent and Are Significantly Associated with Induction Death In Pediatric Acute Promyelocytic Leukemia, a Report From the Children's Oncology Group

Preliminary Results from the North American Acute Promyelocytic Leukemia (APL) Study C9710.

Obesity in Newly Diagnosed Childhood Acute Promyelocytic Leukemia.

Phase III Trial of All-Trans Retinoic Acid (ATRA) vs Daunorubicin (D) and Cytosine Arabinoside (A) as Induction Therapy and ATRA vs Observation as Maintenance Therapy for Children with Newly Diagnosed Acute Promyelocytic Leukemia (APL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only